Do investors value the FDA orphan drug designation?
Crossref DOI link: https://doi.org/10.1186/s13023-017-0665-6
Published Online: 2017-06-19
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Miller, Kathleen L.